Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Researchers are investigating whether adding canine mediation to psychomotor therapy can improve the quality of life for adults with epilepsy who have difficulty managing emotions, movement, or spatial awareness. This study explores the effects of interacting with a specially trained dog during therapy on patients anxiety, emotional control, self-esteem, cognition, and seizure frequency. The aim is to provide evidence on the benefits of animal-assisted therapy in this population, which currently lacks data on these effects. Participants are randomly assigned to one of two groups one receives weekly group psychomotor therapy sessions combined with canine mediation, and the other receives standard group psychomotor therapy sessions without animals. Both interventions take place once a week for 10 weeks. The canine mediation involves a trained dog and a certified canine educator working alongside a psychomotor therapist to engage participants in therapeutic activities that focus on emotions and commands. Throughout the study, participants quality of life is assessed at the start and one week after completing the 10 sessions. The study also monitors anxiety, emotional management, cognition, and seizure frequency. Participants must meet specific eligibility criteria, including having pharmacoresistant epilepsy and requiring psychomotor therapy. The study is sponsored by Fondation Ophtalmologique Adolphe de Rothschild and runs from September 2026 to March 2030.